Nab-Paclitaxel-based therapy in the first line treatment of metastatic breast cancer (IBCSG 42-12/BIG 2-12 SNAP) : impact of different schedules on quality of life

Ribi, Karin; Sun, Z; JERUSALEM, Guy; Hasler, U; Colleoni, Marco; von Moos, R; Cortés, J; Vidal, M; Hennessey, B; Walshe, J; Amillano Parraga, K; Morales Murillo, S; Pagani, O; Barbeaux, A; Borstnar, S; Maibach, R; Regan, MM; Gennari, A; Bernhard, J

Poster (Scientific congresses and symposiums)

Ribi, Karin; Sun, Z; JERUSALEM, Guy et al.

2017 • SABCS

Permalink
https://hdl.handle.net/2268/221418

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Nab-Paclitaxel-based therapy in the first line treatment of metastatic breast cancer ... poster.pdf

Publisher postprint (760.92 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology; Nab-Paclitaxel

Disciplines :

Oncology

Author, co-author :

Ribi, Karin

Sun, Z

JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Service d'oncologie médicale

Hasler, U

Colleoni, Marco

von Moos, R

Cortés, J

Vidal, M

Hennessey, B

Walshe, J

More authors (9 more)

Language :

English

Title :

Nab-Paclitaxel-based therapy in the first line treatment of metastatic breast cancer (IBCSG 42-12/BIG 2-12 SNAP) : impact of different schedules on quality of life

Publication date :

December 2017

Event name :

SABCS

Event place :

San Antonio, United States

Event date :

Decembre 5-9, 2017

By request :

Yes

Audience :

International

Available on ORBi :

since 20 March 2018

Statistics

Number of views

60 (2 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics